iothalamate meglumine

FDA Drug Profile — Conray

iothalamate meglumine is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Conray. Available dosage form: injection.

Drug Details

Generic Name
iothalamate meglumine
Brand Names
Conray
Application Number
NDA013295
Sponsor
Liebel-Flarsheim Company LLC
NDC Codes
1
Dosage Forms
INJECTION
Routes
INTRAVASCULAR
Active Ingredients
IOTHALAMATE MEGLUMINE

Indications and Usage

INDICATIONS AND USAGE Cysto-Conray II is indicated for use in retrograde cystography and cystourethrography.

Warnings

WARNINGS SEVERE ADVERSE EVENTS – INADVERTENT INTRATHECAL ADMINISTRATION: Serious adverse reactions have been reported due to the inadvertent intrathecal administration of iodinated contrast media that are not indicated for intrathecal use. These serious adverse reactions include: death, convulsions, cerebral hemorrhage, coma, paralysis, arachnoiditis, acute renal failure, cardiac arrest, seizures, rhabdomyolysis, hyperthermia, and brain edema. Special attention must be given to ensure that this drug product is not administered intrathecally.